VRBCF / Virbac SA - SEC-arkivering, Årsberetning, Fuldmagtserklæring

Financial Statements and Exhibits, Other Events

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): November 1, 2006 VIRBAC CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 0-24312 43-1648680 (State of Incorporation) (Commission File No.) (IR

VIRBAC S.A. SUCCESSFULLY COMPLETES CASH TENDER OFFER FOR VIRBAC CORPORATION

Exhibit 99.1 For Immediate Release VIRBAC S.A. SUCCESSFULLY COMPLETES CASH TENDER OFFER FOR VIRBAC CORPORATION Carros, France, and Fort Worth, Texas – November 1, 2006 Virbac S.A. (Euronext – Compartiment B / Code ISIN: FR0000031577) and Virbac Corporation (Nasdaq – VBAC) announced today that Labogroup Holding, Inc., an indirect wholly owned subsidiary of Virbac S.A. (“Labogroup”), has successfull

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): October 16, 2006 VIRBAC CORPORATI

e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): October 16, 2006 VIRBAC CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 0-24312 43-1648680 (State of Incorporation) (Commission File No.) (IRS Employer Id

VIRBAC CORPORATION ANNOUNCES CHIEF FINANCIAL OFFICER RESIGNS TO PURSUE ANOTHER OPPORTUNITY

Exhibit 99.2 FOR IMMEDIATE RELEASE Company Contact Ms. Jean Nelson Executive Vice-President and Chief Financial Officer 817-831-5030 VIRBAC CORPORATION ANNOUNCES CHIEF FINANCIAL OFFICER RESIGNS TO PURSUE ANOTHER OPPORTUNITY Fort Worth, Texas, October 16, 2006 — Virbac Corporation (NASDAQ: VBAC), a leading provider of veterinary products, today announced that Jean Nelson, Executive Vice-President a

Case 4:04-cv-00133 Document 180 Filed 10/17/2006 Page 1 of 2 IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF TEXAS FORT WORTH DIVISION RICHARD HRENIUK and PETER § LINDELL, Derivatively on Behalf of § VIRBAC CORPORATION § § V. § CIVIL

Exhibit 99.1 Case 4:04-cv-00133 Document 180 Filed 10/17/2006 Page 1 of 2 IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF TEXAS FORT WORTH DIVISION RICHARD HRENIUK and PETER ? LINDELL, Derivatively on Behalf of ? VIRBAC CORPORATION ? ? V. ? CIVIL ACTION NO. 4:04-CV-l33-Y ? (consolidated with 4:04-CV-134-Y) THOMAS L. BELL, et al. ? ? and ? ? PETER LINDELL ? ? V. ? ? THOMAS L. BELL,

________________________________________________________________________________ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9/ A (Amendment No. 2) Solicitation/ Recommendation Statement under Section 14(d)(4) of the Securi

Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9/ A (Amendment No. 2) Solicitation/ Recommendation Statement under Section 14(d)(4) of the Securities Exchange Act of 1934 VIRBAC CORPORATION (Name of Subject Company) VIRBAC CORPORATION (Name of Persons Filing Statement) COMMON STOCK, PAR VALUE $.01 PER SHARE (Title of Class of Securities) 927649 10 (CUSIP N

VIRBAC S.A. INCREASES OFFER FOR PUBLICLY HELD SHARES OF VIRBAC CORPORATION TO $5.75 PER SHARE AND EXTENDS OFFER TO OCTOBER 31, 2006

Exhibit 99.1 For Immediate Release VIRBAC S.A. INCREASES OFFER FOR PUBLICLY HELD SHARES OF VIRBAC CORPORATION TO $5.75 PER SHARE AND EXTENDS OFFER TO OCTOBER 31, 2006 Carros, France, and Fort Worth, Texas — October 10, 2006 Virbac S.A. (Euronext — Compartiment B / Code ISIN: FR0000031577) and Virbac Corporation (Nasdaq — VBAC) announced today that Labogroup Holding, Inc., an indirect wholly owned

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): October 11, 2006 VIRBAC CORPORATI

e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): October 11, 2006 VIRBAC CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware (State of Incorporation) 0-24312 (Commission File No.) 43-1648680 (IRS Employer Id

To: Insiders (as defined in the Virbac Corporation Insider Trading Policy), Active Virbac Employees, Terminated Employees who are currently participating in the Virbac Corporation Retirement Savings Plan # 4-24872 and the Virbac Corporation Retiremen

Exhibit 99.1 To: Insiders (as defined in the Virbac Corporation Insider Trading Policy), Active Virbac Employees, Terminated Employees who are currently participating in the Virbac Corporation Retirement Savings Plan # 4-24872 and the Virbac Corporation Retirement Savings Plan for Certain Union Members #4-25073 CC: Eric Marée, Alec Poitevint, Michel Garaudet, John Willk, Pierre Pagés, Richard Pick

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): September 15, 2006 VIRBAC CORPORATION (Exact na

e8vk Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): September 15, 2006 VIRBAC CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 0-24312 (Commission File No.) 43-1648680 (IRS E

________________________________________________________________________________ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9/ A (Amendment No. 1) Solicitation/ Recommendation Statement under Section 14(d)(4) of the Securi

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9/ A (Amendment No. 1) Solicitation/ Recommendation Statement under Section 14(d)(4) of the Securities Exchange Act of 1934 VIRBAC CORPORATION (Name of Subject Company) VIRBAC CORPORATION (Name of Persons Filing Statement) COMMON STOCK, PAR VALUE $.01 PER SHARE (Title of Class of Securities) 927649 10 (CUSIP Number of Common St

Virbac Corporation 3200 Meacham Blvd. Fort Worth, Texas 76137

Exhibit (a)(2)(B) Virbac Corporation 3200 Meacham Blvd. Fort Worth, Texas 76137 September 8, 2006 Dear Stockholder: As we informed you in our previous letter to you, dated August 18, 2006, the Company has entered into a tender offer and merger agreement with Virbac S.A., Interlab S.A.S. and Labogroup Holding, Inc., pursuant to which Labogroup Holding, Inc., an indirect wholly owned subsidiary of V

Virbac S.A. Commences Tender Offer for All Publicly Held Shares of Virbac Corporation

exv99wxayx5yxhy Exhibit (a)(5)(h) For Immediate Release Virbac S.A. Commences Tender Offer for All Publicly Held Shares of Virbac Corporation Carros, France, and Fort Worth, Texas — August 18, 2006 — Virbac S.A. (Euronext — Compartiment B / Code ISIN: FR0000031577) and Virbac Corporation (Nasdaq — VBAC) announced today that Labogroup Holding, Inc., a U.S. wholly owned subsidiary of Virbac S.A. (“L

Virbac Corporation 3200 Meacham Blvd. Fort Worth, Texas 76137

Exhibit (a)(2) Virbac Corporation 3200 Meacham Blvd. Fort Worth, Texas 76137 August 18, 2006 Dear Stockholder: We are pleased to inform you that the Company has entered into a tender offer and merger agreement with Virbac S.A., Interlab S.A.S. and Labogroup Holding, Inc., pursuant to which Labogroup Holding, Inc., an indirect wholly owned subsidiary of Virbac S.A., has commenced an offer to purcha

________________________________________________________________________________ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 Solicitation/ Recommendation Statement under Section 14(d)(4) of the Securities Exchange Act of

sc14d9 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 Solicitation/ Recommendation Statement under Section 14(d)(4) of the Securities Exchange Act of 1934 VIRBAC CORPORATION (Name of Subject Company) VIRBAC CORPORATION (Name of Persons Filing Statement) COMMON STOCK, PAR VALUE $.01 PER SHARE (Title of Class of Securities) 927649 10 (CUSIP Number of Common Stock) Jean M. N

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): August 15, 2006 VIRBAC CORPORATION (Exact name

e8vk SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): August 15, 2006 VIRBAC CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-24312 43-1648680 (State of incorporation) (Commission File No.) (IRS Employer Identificatio

To: Insiders (as defined in the Virbac Corporation Insider Trading Policy), Active Virbac Employees, Terminated Employees who are currently participating in the Virbac Corporation Retirement Savings Plan # 4-24872 and the Virbac Corporation Retiremen

exv99w1 Exhibit 99.1 To: Insiders (as defined in the Virbac Corporation Insider Trading Policy), Active Virbac Employees, Terminated Employees who are currently participating in the Virbac Corporation Retirement Savings Plan # 4-24872 and the Virbac Corporation Retirement Savings Plan for Certain Union Members #4-25073 CC: Eric Marée, Alec Poitevint, Michel Garaudet, John Willk, Pierre Pagés, Rich

Loan Agreement

exv10w3 LOAN AGREEMENT BY AND AMONG VIRBAC CORPORATION, PM RESOURCES, INC., ST. JON LABORATORIES, INC., FRANCODEX LABORATORIES, INC., VIRBAC AH, INC., DELMARVA LABORATORIES, INC., THE LENDERS PARTY HERETO AND FIRST BANK, AS AGENT FOR LENDERS June 29, 2006 TABLE OF CONTENTS Page SECTION 1. TERM 4 SECTION 2. DEFINITIONS 4 SECTION 3. THE REVOLVING CREDIT LOANS 18 3.1 Revolving Credit Commitment of Le

VIRBAC CORPORATION ANNOUNCES RECORD SECOND QUARTER REVENUES OF $25 MILLION AND RECORD QUARTERLY EARNINGS OF $0.14 PER SHARE

exv99w1 Exhibit 99.1 FOR IMMEDIATE RELEASE Company Contact Ms. Jean M. Nelson Executive Vice-President and Chief Financial Officer 817-831-5030 VIRBAC CORPORATION ANNOUNCES RECORD SECOND QUARTER REVENUES OF $25 MILLION AND RECORD QUARTERLY EARNINGS OF $0.14 PER SHARE Fort Worth, Texas, August 11, 2006 — Virbac Corporation (NASDAQ — VBAC), a leading provider of veterinary products, today announced

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): August 11, 2006 VIRBAC CORPORATIO

e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): August 11, 2006 VIRBAC CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 0-24312 43-1648680 (State of Incorporation) (Commission File No.) (IRS Employer Ide

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2006 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-2

Virbac S.A. and Virbac Corporation Sign Tender Offer and Merger Agreement

exv99w1 Exhibit 99.1 For Immediate Release Virbac S.A. and Virbac Corporation Sign Tender Offer and Merger Agreement Carros, France, and Fort Worth, Texas — August 10, 2006 — Virbac S.A. (Euronext — Compartiment B / Code ISIN: FR0000031577) and Virbac Corporation (Nasdaq — VBAC) announced that they have signed today a Tender Offer and Merger Agreement, pursuant to which Labogroup Holding, Inc., a

Tender Offer and Merger Agreement

exv2w1 Exhibit 2.1 EXECUTION COPY TENDER OFFER AND MERGER AGREEMENT by and among VIRBAC S.A. INTERLAB S.A.S. LABOGROUP HOLDING, INC. and VIRBAC CORPORATION August 10, 2006 TABLE OF CONTENTS Page ARTICLE I THE OFFER AND MERGER 2 Section 1.1. The Offer 2 Section 1.2. Company Actions 3 Section 1.3. The Merger 5 Section 1.4. Effective Time 5 Section 1.5. Certificate of Incorporation and By-laws 5 Sect

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): August 10, 2006 VIRBAC CORPORATIO

e8vk Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): August 8, 2006 VIRBAC CORPORATION

e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): August 8, 2006 VIRBAC CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware (State of Incorporation) 0-24312 (Commission File No.) 43-1648680 (IRS Employer Iden

VIRBAC CORPORATION AND VIRBAC S.A. REACH AGREEMENT FOR VIRBAC S.A. TO ACQUIRE ALL REMAINING OUTSTANDING SHARES OF VIRBAC CORPORATION NOT ALREADY OWNED FOR $5.25 PER SHARE; SPECIAL COMMITTEE OF VIRBAC CORPORATION AGREES TO RECOMMEND OFFER

exv99w1 Exhibit 99.1 FOR IMMEDIATE RELEASE Company Contact Ms. Jean M. Nelson Executive Vice-President and Chief Financial Officer 817-831-5030 VIRBAC CORPORATION AND VIRBAC S.A. REACH AGREEMENT FOR VIRBAC S.A. TO ACQUIRE ALL REMAINING OUTSTANDING SHARES OF VIRBAC CORPORATION NOT ALREADY OWNED FOR $5.25 PER SHARE; SPECIAL COMMITTEE OF VIRBAC CORPORATION AGREES TO RECOMMEND OFFER Fort Worth, Texas

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): June 29, 2006 VIRBAC CORPORATION

e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): June 29, 2006 VIRBAC CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware (State of Incorporation) 0-24312 (Commission File No.) 43-1648680 (IRS Employer Ident

VIRBAC CORPORATION ANNOUNCES RECEIPT OF REVISED PROPOSAL FROM VIRBAC S.A. TO ACQUIRE ALL REMAINING OUTSTANDING SHARES OF VIRBAC CORPORATION NOT ALREADY OWNED

exv99w1 Exhibit 99.1 FOR IMMEDIATE RELEASE Company Contact Ms. Jean M. Nelson Executive Vice-President and Chief Financial Officer 817-831-5030 VIRBAC CORPORATION ANNOUNCES RECEIPT OF REVISED PROPOSAL FROM VIRBAC S.A. TO ACQUIRE ALL REMAINING OUTSTANDING SHARES OF VIRBAC CORPORATION NOT ALREADY OWNED Fort Worth, Texas July 11, 2006 — Virbac Corporation (NASDAQ: VBAC), a leading provider of veterin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): July 11, 2006 VIRBAC CORPORATION

e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): July 11, 2006 VIRBAC CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware (State of Incorporation) 0-24312 (Commission File No.) 43-1648680 (IRS Employer Ident

June 29, 2006

Exhibit 10.2 June 29, 2006 Virbac Corporation and Subsidiaries 3200 Meacham Boulevard Fort Worth, Texas 76137 Attention: Jean M. Nelson, Executive Vice President and Chief Financial Officer Re: Amendment re Execution of Syndicated Loan Documents Dear Ms. Nelson: It is evident that the requirement of Paragraph 8 of the Ninth Amendment to Credit Agreement dated as of March 24, 2006 made by and among

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): June 30, 2006 VIRBAC CORPORATION

e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): June 30, 2006 VIRBAC CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware (State of Incorporation) 0-24312 (Commission File No.) 43-1648680 (IRS Employer Ident

VIRBAC CORPORATION SETTLES WITH THE SEC

exv99w1 Exhibit 99.1 FOR IMMEDIATE RELEASE Company Contact Ms. Jean M. Nelson Executive Vice-President and Chief Financial Officer 817-831-5030 VIRBAC CORPORATION SETTLES WITH THE SEC Fort Worth, Texas, June 29, 2006 — Virbac Corporation (NASDAQ: VBAC), a leading provider of veterinary products, today announced that its settlement with the U.S. Securities and Exchange Commission (the “SEC”) has be

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): June 29, 2006 VIRBAC CORPORATION

e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): June 29, 2006 VIRBAC CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 0-24312 43-1648680 (State of Incorporation) (Commission File No.) (IRS Employer Ident

VIRBAC CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 11-K þ ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (No Fee Required) For the fiscal year ended December 31, 2005 o TRANS

e11vk Table of Contents VIRBAC CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.

To: Insiders (as defined in the Virbac Corporation Insider Trading Policy), Active Virbac Employees, Terminated Employees who are currently participating in the Virbac Corporation Retirement Savings Plan # 4-24872 and the Virbac Corporation Retiremen

exv99w1 Exhibit 99.1 To: Insiders (as defined in the Virbac Corporation Insider Trading Policy), Active Virbac Employees, Terminated Employees who are currently participating in the Virbac Corporation Retirement Savings Plan # 4-24872 and the Virbac Corporation Retirement Savings Plan for Certain Union Members #4-25073 CC: Eric Marée, Alec Poitevint, Michel Garaudet, John Willk, Pierre Pagés, Rich

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): May 23, 2006 VIRBAC CORPORATION (Exact name of

e8vk SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): May 23, 2006 VIRBAC CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 0-24312 (Commission File No.) 43-1648680 (IRS Employer Identification N

To: Insiders (as defined in the Virbac Corporation Insider Trading Policy), Active Virbac Employees, Terminated Employees who are currently participating in the Virbac Corporation Retirement Savings Plan # 4-24872 and the Virbac Corporation Retiremen

exv99w1 Exhibit 99.1 To: Insiders (as defined in the Virbac Corporation Insider Trading Policy), Active Virbac Employees, Terminated Employees who are currently participating in the Virbac Corporation Retirement Savings Plan # 4-24872 and the Virbac Corporation Retirement Savings Plan for Certain Union Members #4-25073 CC: Eric Marée, Alec Poitevint, Michel Garaudet, John Willk, Pierre Pagès, Rich

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): May 17, 2006 VIRBAC CORPORATION (Exact name of

e8vk SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): May 17, 2006 VIRBAC CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 0-24312 (Commission File No.) 43-1648680 (IRS Employer Identification N

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): May 15, 2006 VIRBAC CORPORATION (

e8vk Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

VIRBAC CORPORATION ANNOUNCES FIRST QUARTER NET INCOME OF $0.4 MILLION ON REVENUES OF $19.7 MILLION

exv99w1 Exhibit 99.1 FOR IMMEDIATE RELEASE Company Contact Ms. Jean M. Nelson Executive Vice-President and Chief Financial Officer 817-831-5030 VIRBAC CORPORATION ANNOUNCES FIRST QUARTER NET INCOME OF $0.4 MILLION ON REVENUES OF $19.7 MILLION Fort Worth, Texas, May 15, 2006 — Virbac Corporation (VBAC), a leading provider of veterinary products, today announced its earnings for the three months end

Tenth Amendment to Credit Agreement

exv10w2 Exhibit 10.2 May 8, 2006 Virbac Corporation and Subsidiaries 3200 Meacham Boulevard Fort Worth, Texas 76137 Attention: Jean M. Nelson, Executive Vice President and Chief Financial Officer Re: Amendment re Delivery of New Amended and Restated Loan Agreement Dear Ms. Nelson: It is evident that the requirement of Paragraph 8 of the Ninth Amendment to Credit Agreement dated as of March 24, 200

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

e10vq Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): May 15, 2006 VIRBAC CORPORATION (

e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): May 15, 2006 VIRBAC CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware (State of Incorporation) 0-24312 (Commission File No.) 43-1648680 (IRS Employer Identi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): May 8, 2006 VIRBAC CORPORATION (E

e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): May 8, 2006 VIRBAC CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware (State of Incorporation) 0-24312 (Commission File No.) 43-1648680 (IRS Employer Identif

VIRBAC CORPORATION ANNOUNCES LISTING OF ITS COMMON STOCK ON THE NASDAQ CAPITAL MARKET

exv99w1 Exhibit 99.1 FOR IMMEDIATE RELEASE Company Contact Ms. Jean M. Nelson Executive Vice-President and Chief Financial Officer 817-831-5030 VIRBAC CORPORATION ANNOUNCES LISTING OF ITS COMMON STOCK ON THE NASDAQ CAPITAL MARKET Fort Worth, Texas, May 8, 2006 — Virbac Corporation (PK: VBAC), a leading provider of veterinary products, today announced The NASDAQ Listing Qualifications Department ap

To: Insiders (as defined in the Virbac Corporation Insider Trading Policy), Active Virbac Employees, Terminated Employees who are currently participating in the Virbac Corporation Retirement Savings Plan # 4-24872 and the Virbac Corporation Retiremen

exv99w1 Exhibit 99.1 To: Insiders (as defined in the Virbac Corporation Insider Trading Policy), Active Virbac Employees, Terminated Employees who are currently participating in the Virbac Corporation Retirement Savings Plan # 4-24872 and the Virbac Corporation Retirement Savings Plan for Certain Union Members #4-25073 CC: Eric Maree, Alec Pointevent, Michel Garaudet, John Wilk, Pierre Pages, Rich

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): May 8, 2006 VIRBAC CORPORATION (Exact name of r

e8vk Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): May 8, 2006 VIRBAC CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 0-24312 (Commission File No.) 43-1648680 (IRS Employer

Audit Committee Charter

exv99w1 Exhibit 99.1 VIRBAC CORPORATION AUDIT COMMITTEE CHARTER The Audit Committee (the “Committee”) of Virbac Corporation (the “Corporation”) is responsible for providing assistance to the Board of Directors in overseeing (i) the integrity of the financial statements of the Corporation, (ii) the independent auditor’s qualifications and independence, (iii) the performance of the Corporation’s ind

Employment Agreement - Laurent Cesar

exv10w11 Exhibit 10.11 EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”), dated as of April 25, 2005, effective as of April 1, 2005 (the “Effective Date”), is executed by and between Virbac Corporation, a Texas corporation with its principal place of business located at 3200 Meacham Blvd., Ft. Worth , TX 76137 (the “Company”), and Laurent Cesar, an individual residing at 3605 Autumn

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1)

e10vkza Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

VIRBAC CORPORATION ANNOUNCES RECORD 2005 EARNINGS OF $0.17 PER SHARE ON REVENUES OF $80.8 MILLION

exv99w1 FOR IMMEDIATE RELEASE Company Contact Ms. Jean M. Nelson Executive Vice-President and Chief Financial Officer 817-831-5030 VIRBAC CORPORATION ANNOUNCES RECORD 2005 EARNINGS OF $0.17 PER SHARE ON REVENUES OF $80.8 MILLION Fort Worth, Texas, March 31, 2006 — Virbac Corporation (PK: VBAC), a leading provider of veterinary products, today announced its earnings for the year and three months en

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): March 31, 2006 VIRBAC CORPORATION

e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): March 31, 2006 VIRBAC CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 0-24312 43-1648680 (State of Incorporation) (Commission File No.) (IRS Employer Iden

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

e10vk Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

Third Amendment to Secured Subordinated Promissory Note dated April 29, 2004

Exhibit 10.46 THIRD AMENDMENT TO SECURED SUBORDINATED PROMISSORY NOTE DATED AS OF APRIL 29, 2004 This Third Amendment is made as of the 7th day of March, 2006, by and among Virbac Corporation, a Delaware corporation, PM Resources, Inc., a Missouri corporation, St. Jon Laboratories, Inc., a California corporation, Francodex Laboratories, Inc., a Kansas corporation, Delmarva Laboratories, Inc., a Vi

Third Amendment to Secured Subordinated Promissory Note dated April 9, 2004

exv10w45 Exhibit 10.45 THIRD AMENDMENT TO SECURED SUBORDINATED PROMISSORY NOTE DATED AS OF APRIL 9, 2004 This Third Amendment is made as of the 7th day of March, 2006, by and among Virbac Corporation, a Delaware corporation, PM Resources, Inc., a Missouri corporation, St. Jon Laboratories, Inc., a California corporation, Francodex Laboratories, Inc., a Kansas corporation, Delmarva Laboratories, In

Ninth Amendment to Credit Agreement

exv10w27 Exhibit 10.27 NINTH AMENDMENT TO CREDIT AGREEMENT THIS NINTH AMENDMENT TO CREDIT AGREEMENT (this “Ninth Amendment to Credit Agreement”), made and entered into as of the 24th day of March, 2006, by and between VIRBAC CORPORATION, a Delaware corporation (“Virbac”), PM RESOURCES, INC., a Missouri corporation (“PM Resources”), ST. JON LABORATORIES, INC., a California corporation (“St. JON”),

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): December 16, 2005 VIRBAC CORPORATION (Exact nam

e8vk SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): December 16, 2005 VIRBAC CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 0-24312 (Commission File No.) 43-1648680 (IRS Employer Identificat

To: Insiders (as defined in the Virbac Corporation Insider Trading Policy), Active Virbac Employees, Terminated Employees who are currently participating in the Virbac Corporation Retirement Savings Plan # 4-24872 and the Virbac Corporation Retiremen

exv99w1 Exhibit 99.1 To: Insiders (as defined in the Virbac Corporation Insider Trading Policy), Active Virbac Employees, Terminated Employees who are currently participating in the Virbac Corporation Retirement Savings Plan # 4-24872 and the Virbac Corporation Retirement Savings Plan for Certain Union Members #4-25073 From: Chief Financial Officer, Compliance Officer Re: Blackout Period Date: Dec

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): March 9, 2006 VIRBAC CORPORATION

e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): March 9, 2006 VIRBAC CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware (State of Incorporation) 0-24312 (Commission File No.) 43-1648680 (IRS Employer Ident

VIRBAC CORPORATION APPOINTS SPECIAL COMMITTEE OF BOARD OF DIRECTORS TO REVIEW TERMS OF TENDER OFFER BY VIRBAC S.A.

exv99w1 Exhibit 99.1 FOR IMMEDIATE RELEASE Company Contact Ms. Jean M. Nelson Executive Vice-President and Chief Financial Officer 817-831-5030 VIRBAC CORPORATION APPOINTS SPECIAL COMMITTEE OF BOARD OF DIRECTORS TO REVIEW TERMS OF TENDER OFFER BY VIRBAC S.A. Fort Worth, Texas, March 14, 2006 — Virbac Corporation (PK: VBAC), a leading provider of veterinary products, today announced that its Board

DIRECTOR’S INDEMNIFICATION AGREEMENT

Exhibit 99.2 DIRECTOR?S INDEMNIFICATION AGREEMENT This Director?s Indemnification Agreement (?Agreement?) is made as of , 2006 (the ?Effective Date?) by and between Virbac Corporation, a Delaware corporation (the ?Company?), and who serves as a Director of the Company (?Indemnitee?). RECITALS WHEREAS, highly competent persons have become more reluctant to serve corporations as Directors unless the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): December 1, 2005 VIRBAC CORPORATI

e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): December 1, 2005 VIRBAC CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of Incorporation) 0-24312 (Commission File No.) 43-1648680 (IRS Employe

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): December 13, 2005 VIRBAC CORPORAT

e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): December 13, 2005 VIRBAC CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of Incorporation) 0-24312 (Commission File No.) 43-1648680 (IRS Employ

VIRBAC CORPORATION ANNOUNCES VIRBAC S.A. PROPOSAL TO ACQUIRE ALL REMAINING OUTSTANDING SHARES OF VIRBAC CORPORATION NOT ALREADY OWNED

exv99w1 Exhibit 99.1 FOR IMMEDIATE RELEASE Company Contact Ms. Jean M. Nelson Executive Vice-President and Chief Financial Officer 817-831-5030 VIRBAC CORPORATION ANNOUNCES VIRBAC S.A. PROPOSAL TO ACQUIRE ALL REMAINING OUTSTANDING SHARES OF VIRBAC CORPORATION NOT ALREADY OWNED Fort Worth, Texas, December 13, 2005 — Virbac Corporation (PK: VBAC), a leading provider of veterinary products, today ann

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1)

e10vkza UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2004 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUM

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1)

e10vkza Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): November 9, 2005 VIRBAC CORPORATI

e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): November 9, 2005 VIRBAC CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of Incorporation) 0-24312 (Commission File No.) 43-1648680 (IRS Employe

To: Insiders (as defined in the Virbac Corporation Insider Trading Policy), Active Virbac Employees, Terminated Employees who are currently participating in the Virbac Corporation Retirement Savings Plan #4-24872 and the Virbac Corporation Retirement

exv99w1 EXHIBIT 99.1 To: Insiders (as defined in the Virbac Corporation Insider Trading Policy), Active Virbac Employees, Terminated Employees who are currently participating in the Virbac Corporation Retirement Savings Plan #4-24872 and the Virbac Corporation Retirement Savings Plan for Certain Union Members #4-25073 From: Chief Financial Officer, Compliance Officer Re: Expiration of Special Blac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): November 9, 2005 VIRBAC CORPORATI

e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): November 9, 2005 VIRBAC CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-24312 43-1648680 (State of Incorporation) (Commission File No.) (IRS Employe

VIRBAC CORPORATION ANNOUNCES 2005 NINE MONTH EARNINGS OF $0.13 PER SHARE ON REVENUES OF $61.2 MILLION

exv99w1 Exhibit 99.1 FOR IMMEDIATE RELEASE Company Contact Ms. Jean M. Nelson Executive Vice-President and Chief Financial Officer 817-831-5030 VIRBAC CORPORATION ANNOUNCES 2005 NINE MONTH EARNINGS OF $0.13 PER SHARE ON REVENUES OF $61.2 MILLION Fort Worth, Texas, November 9, 2005 — Virbac Corporation (PK: VBAC), a leading provider of veterinary products, today announced its earnings for the three

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

e10vq Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Ame

def14a Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): October 26, 2005 VIRBAC CORPORATION (Exact name

e8vk SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): October 26, 2005 VIRBAC CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of Incorporation) 0-24312 (Commission File No.) 43-1648680 (IRS Employer Identificati

VIRBAC CORPORATION ANNOUNCES FIRST HALF OF 2005 EARNINGS OF $0.11 PER SHARE ON REVENUES OF $41.1 MILLION

exv99w1 Exhibit 99.1 FOR IMMEDIATE RELEASE Company Contact Ms. Jean M. Nelson Executive Vice-President and Chief Financial Officer 817-831-5030 VIRBAC CORPORATION ANNOUNCES FIRST HALF OF 2005 EARNINGS OF $0.11 PER SHARE ON REVENUES OF $41.1 MILLION Fort Worth, Texas, October 26, 2005 — Virbac Corporation (PK: VBAC), a leading provider of veterinary products, today announced its earnings for the fi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

e10vq Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

e10vq Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Other Events

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): October 7, 2005 VIRBAC CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-24312 43-1648680 (State of Incorporation) (Commission File No.) (IRS Employer Identification No.

Financial Statements and Exhibits, Other Events

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): September 23, 2005 VIRBAC CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of Incorporation) 0-24312 (Commission File No.) 43-1648680 (IRS Employer Identification

VIRBAC CORPORATION ANNOUNCES 2005 ANNUAL SHAREHOLDER MEETING

exv99w1 Exhibit 99.1 FOR IMMEDIATE RELEASE Company Contact Ms. Jean M. Nelson Executive Vice-President and Chief Financial Officer 817-831-5030 VIRBAC CORPORATION ANNOUNCES 2005 ANNUAL SHAREHOLDER MEETING Fort Worth, Texas, September 23, 2005 — Virbac Corporation (OTC Pink Sheets: VBAC), a leading provider of veterinary products, today announced that it will hold its 2005 Annual Shareholder Meetin

Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

8-K 1 d28757e8vk.htm FORM 8-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): August 2, 2005 VIRBAC CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-24312 43-1648680 (State of Incorpor

Revolving Credit Note

EXHIBIT 10.4 Revolving Credit Note $15,000,000.00 St. Louis, Missouri August 22, 2005 FOR VALUE RECEIVED, on September 30, 2006 the undersigned, VIRBAC CORPORATION, a Delaware corporation (formerly known as Agri-Nutrition Group Limited), PM RESOURCES, INC., a Missouri corporation, ST. JON LABORATORIES, INC., a California corporation, FRANCODEX LABORATORIES, INC., a Kansas corporation, VIRBAC AH, I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

e10vq Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2004 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

e10vq Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): August 30, 2005 VIRBAC CORPORATION (Exact name

e8vk SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): August 30, 2005 VIRBAC CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of Incorporation) 0-24312 (Commission File No.) 43-1648680 (IRS Employer Identificatio

VIRBAC CORPORATION ANNOUNCES 2004 EARNINGS RESULTS AND THE FILING OF ITS 2004 ANNUAL REPORT ON FORM 10-K

exv99w1 EXHIBIT 99.1 FOR IMMEDIATE RELEASE Company Contact Ms. Jean M. Nelson Executive Vice-President and Chief Financial Officer 817-831-5030 VIRBAC CORPORATION ANNOUNCES 2004 EARNINGS RESULTS AND THE FILING OF ITS 2004 ANNUAL REPORT ON FORM 10-K Fort Worth, Texas, August 30, 2005 — Virbac Corporation (PK: VBAC), a leading provider of veterinary products, today announced that it has filed its 20

Amendment to Subordination Agreement

exv10w44 Exhibit 10.44 AMENDMENT TO SUBORDINATION AGREEMENT THIS AMENDMENT TO SUBORDINATION AGREEMENT (this “Amendment”) is made and entered into this 22nd day of August, 2005, by and between VIRBAC S. A., a business organized under the laws of the Republic of France (the “Subordinating Creditor”) and FIRST BANK, a national banking association (the “Bank”). WITNESSETH WHEREAS, the Subordinating Cr

2nd Amendment to Secured Subordinated Promissory Note

exv10w42 Exhibit 10.42 SECOND AMENDMENT TO SECURED SUBORDINATED PROMISSORY NOTE DATED AS OF APRIL 29, 2004 This Second Amendment is made as of the 2nd day of August, 2005, by and among Virbac Corporation, a Delaware corporation, PM Resources, Inc., a Missouri corporation, St. Jon Laboratories, Inc., a California corporation, Francodex Laboratories, Inc., a Kansas corporation, Delmarva Laboratories

2nd Agreement to Secured Subordinated Promissory Note

exv10w41 Exhibit 10.41 SECOND AMENDMENT TO SECURED SUBORDINATED PROMISSORY NOTE DATED AS OF APRIL 9, 2004 This Second Amendment is made as of the 2nd day of August, 2005, by and among Virbac Corporation, a Delaware corporation, PM Resources, Inc., a Missouri corporation, St.Jon Laboratories, Inc., a California corporation, Francodex Laboratories, Inc., a Kansas corporation, Delmarva Laboratories,

8th Amendment to Credit Agreement

exv10w26 Exhibit 10.26 EIGHTH AMENDMENT TO CREDIT AGREEMENT THIS EIGHTH AMENDMENT TO CREDIT AGREEMENT (this “Eighth Amendment to Credit Agreement”), made and entered into as of the 22nd day of August, 2005, by and between VIRBAC CORPORATION, a Delaware corporation (“Virbac”), PM RESOURCES, INC., a Missouri corporation (“PM Resources”), ST. JON LABORATORIES, INC., a California corporation (“St. JON

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2004 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER: 0-243

Employment Agreement - Jean M. Nelson

exv10w31 Exhibit 10.31 May 20, 2004 Ms. Jean M. Nelson Fax: (419) 730-8737 3368 Blackburn Street Dallas, TX 75204 Dear Jean: I am pleased to offer you the position of Chief Financial Officer of Virbac Corporation (“Virbac”), commencing on June 14, 2004. The following terms have been discussed and agreed: 1) Your base salary will be $240,000 per year. In addition, you will participate in health ins

Employment Agreement - Erik R. Martinez

exv10w32 Exhibit 10.32 EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”), dated as of October 1, 2004, effective as of October 1, 2004 (the “Effective Date”), is executed by and between Virbac Corporation, a Texas corporation with its principal place of business located at 3200 Meacham Blvd., Ft. Worth , TX 76137 (the “Company”), and Erik R. Martinez, an individual residing at 6355

2nd Amendment to Secured Subordinated Promissory Note

exv10w43 Exhibit 10.43 SECOND AMENDMENT TO SECURED SUBORDINATED PROMISSORY NOTE DATED AS OF JUNE 3, 2004 This Second Amendment is made as of the 2nd day of August, 2005, by and among Virbac Corporation, a Delaware corporation, PM Resources, Inc., a Missouri corporation, St. Jon Laboratories, Inc., a California corporation, Francodex Laboratories, Inc., a Kansas corporation, Delmarva Laboratories,

VIRBAC CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 11-K þ ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (No Fee Required) For the fiscal year ended December 31, 2004 o TRANS

e11vk Table of Contents VIRBAC CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): February 8, 2005 VIRBAC CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-24312 43-1648680 (State of Incorporation) (Commission File No.) (IRS Employer

VIRBAC CORPORATION ANNOUNCES KEY EXECUTIVE MANAGEMENT POSITIONS

exv99w1 Exhibit 99.1 FOR IMMEDIATE RELEASE Company Contact Ms. Jean M. Nelson Executive Vice-President and Chief Financial Officer 817-831-5030 VIRBAC CORPORATION ANNOUNCES KEY EXECUTIVE MANAGEMENT POSITIONS Fort Worth, Texas, May 17, 2005 — Virbac Corporation (PK:VBAC) is pleased to announce the appointment of Mike O’Bryan to the position of Executive Vice-President of Business Operations. Previo

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Virbac Corporation (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securitie

sc13dza OMB APPROVAL OMB Number: 3235-0145 Expires: December 31, 2005 Estimated average burden hours per response.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): May 6, 2005 VIRBAC CORPORATION (Exact name of r

e8vk SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): May 6, 2005 VIRBAC CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-24312 43-1648680 (State of Incorporation) (Commission File No.) (IRS Employer Identification No

First Amendment to Secured Subordinated Promissory Note dated June 3, 2004

FIRST AMENDMENT TO SECURED SUBORDINATED PROMISSORY NOTE DATED AS OF JUNE 3, 2004 This First Amendment is made as of the 24th day of March, 2005, by and among Virbac Corporation, a Delaware corporation, PM Resources, Inc.

Secured Subordinated Promissory Note for $4,000,000

VIRBAC CORPORATION FORM 10-Q SEPTEMBER 30, 2003 Exhibit 10.15 Secured Subordinated Promissory Note for $4,000,000 by and among Virbac Corporation, PM Resources, Inc., St. JON Laboratories, Inc., Francodex Laboratories, Inc., Virbac AH, Inc., Delmarva Laboratories, Inc., and Virbac, S.A., dated April 29, 2004. THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED ("THE SECU

Amendment to Forebearance Agreement

April 1, 2005 Virbac Corporation and Subsidiaries 3200 Meacham Boulevard Fort Worth, Texas 76137 Attention: Jean M.

Fifth Amendment to Credit Agreement

FIFTH AMENDMENT TO CREDIT AGREEMENT THIS FIFTH AMENDMENT TO CREDIT AGREEMENT, made and entered into as of the 11th day of August, 2003, by and between VIRBAC CORPORATION, a Delaware corporation ("Virbac"), PM RESOURCES, INC.

Third Amendment to Forbearance Agreement

THIRD AMENDMENT TO FORBEARANCE AGREEMENT THIS THIRD AMENDMENT TO FORBEARANCE AGREEMENT, made and entered into as of the 7th day of February, 2005, by and between VIRBAC CORPORATION, a Delaware corporation ("Virbac"), PM RESOURCES, INC.

Stock Purchase Agreement

VIRBAC CORPORATION FORM 10-Q SEPTEMBER 30, 2003 Exhibit 2.2 Stock Purchase Agreement by and between Virbac Corporation and Delmarva Laboratories, Inc. dated as of August 15, 2003. [BLANK ROME LLP LOGO] PHONE: (202) 944-3525 FAX: (202) 944-3068 EMAIL: [email protected] August 15, 2003 Joseph A. Rougraff Chief Financial Officer Virbac 3200 Meacham Blvd. Ft. Worth, TX 76137 Re: Acquisition of Delm

Seventh Amendment to Credit Agreement

SEVENTH AMENDMENT TO CREDIT AGREEMENT AND AMENDMENT TO NOTE THIS SEVENTH AMENDMENT TO CREDIT AGREEMENT AND AMENDMENT TO NOTE (this "Seventh Amendment to Credit Agreement"), made and entered into as of the 1st day of March, 2004, by and between VIRBAC CORPORATION, a Delaware corporation ("Virbac"), PM RESOURCES, INC.

Secured Subordinated Promissory Note for $3,000,000

VIRBAC CORPORATION FORM 10-Q SEPTEMBER 30, 2003 Exhibit 10.14 Secured Subordinated Promissory Note for $3,000,000 by and among Virbac Corporation, PM Resources, Inc., St. JON Laboratories, Inc., Francodex Laboratories, Inc., Virbac AH, Inc., Delmarva Laboratories, Inc., and Virbac, S.A., dated April 9, 2004. THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED ("THE SECUR

First Amendment to Secured Subordinated Promissory Note dated April 29, 2004

FIRST AMENDMENT TO SECURED SUBORDINATED PROMISSORY NOTE DATED AS OF APRIL 29, 2004 This First Amendment is made as of the 24th day of March, 2005, by and among Virbac Corporation, a Delaware corporation, PM Resources, Inc.

Fifth Amendment to Forbearance Agreement

FIFTH AMENDMENT TO FORBEARANCE AGREEMENT - THIS FIFTH AMENDMENT TO FORBEARANCE AGREEMENT, made and entered into as of the 6th day of May, 2005, by and between VIRBAC CORPORATION, a Delaware corporation ("Virbac"), PM RESOURCES, INC.

Acknowledgement of Extended Maturity Date

ACKNOWLEDGEMENT OF EXTENDED MATURITY DATE Virbac Corporation, PM Resources, Inc., St. Jon Laboratories, Inc., Francodex Laboratories, Inc., Delmarva Laboratories, Inc. and Virbac AH, Inc. are the Borrowers under the Secured Subordinated Promissory Note dated as of April 9, 2004 and the Secured Subordinated Promissory Note dated April 29, 2004, both in favor of Virbac S.A. (the "Notes"). Capitalize

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2003 or o TRANSITION REPORT PURSU

e10vq Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

EX-10.27

EXHIBIT 10.27 April 15, 2005 Virbac Corporation and Subsidiaries 3200 Meacham Boulevard Fort Worth, Texas 76137 Attention: Jean M. Nelson, Executive Vice President and Chief Financial Officer Re: Waiver of 2001 and 2002 Financial Covenant Defaults and Amendments to Forbearance Agreement Dear Ms. Nelson: Reference is made to that certain Credit Agreement dated as of September 7, 1999 made by and am

First Amendment to Secured Subordinated Promissory Note

FIRST AMENDMENT TO SECURED SUBORDINATED PROMISSORY NOTE DATED AS OF APRIL 9, 2004 This First Amendment is made as of the 24th day of March, 2005, by and among Virbac Corporation, a Delaware corporation, PM Resources, Inc.

Waiver of September 30, 3002 10-Q Reporting Period from First Bank

VIRBAC CORPORATION FORM 10-Q SEPTEMBER 30, 2003 Exhibit 10.12 Waiver of September 30, 2003 10-Q Reporting Period from First Bank, dated November 12, 2003. [FIRST BANK LOGO] November 12, 2003 Virbac Corporation 3200 Meacham Blvd. Ft. Worth, TX 76137 Attn: Joe Rougraff Re: Waiver of September 30, 2003 10-Q Reporting Period Gentlemen: You have informed First Bank and Bank One ("Lenders") of the nonco

Second Amendment to Forebearance Agreement

SECOND AMENDMENT TO FORBEARANCE AGREEMENT THIS SECOND AMENDMENT TO FORBEARANCE AGREEMENT, made and entered into as of the 9th day of August, 2004, by and between VIRBAC CORPORATION, a Delaware corporation ("Virbac"), PM RESOURCES, INC.

Amended and Restated By-Laws

BYLAWS OF VIRBAC CORPORATION (Amended and Restated as of January 27, 2004) ARTICLE I - OFFICES SECTION 1.

Forebearance Agreement

FORBEARANCE AGREEMENT THIS AGREEMENT dated as of April 9, 2004 by and between VIRBAC CORPORATION, a Delaware corporation ("Virbac"), PM RESOURCES, INC.

Secured Subordinated Promissory Note for $2,000,000

VIRBAC CORPORATION FORM 10-Q SEPTEMBER 30, 2003 Exhibit 10.19 Secured Subordinated Promissory Note for $2,000,000 by and among Virbac Corporation, PM Resources, Inc., St. JON Laboratories, Inc., Francodex Laboratories, Inc., Virbac AH, Inc., Delmarva Laboratories, Inc., and Virbac, S.A., dated June 4, 2004. THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED ("THE SECURI

Amendment to Forebearance Agreement

AMENDMENT TO FORBEARANCE AGREEMENT THIS AMENDMENT TO FORBEARANCE AGREEMENT, made and entered into as of the 10th day of May, 2004, by and between VIRBAC CORPORATION, a Delaware corporation ("Virbac"), PM RESOURCES, INC.

Acknowledgment of 2005 Extended Maturity Date

ACKNOWLEDGEMENT OF 2005 EXTENDED MATURITY DATE Virbac Corporation, PM Resources, Inc.

Unaudited Pro Forma Condensed Combined Financial Statements

EXHIBIT 99.4 VIRBAC CORPORATION UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENTS OF OPERATIONS On September 8, 2003, Virbac Corporation ("Virbac" or the "Company") completed the acquisition of assets relating to the animal health products of King Pharmaceuticals, Inc. ("King"), for a purchase price of $15.2 million in cash. The acquired assets include certain product assets, unfilled customer ord

Charter of the Audit Committee of the Board of Directors

EXHIBIT 99.1 VIRBAC CORPORATION CHARTER OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS 1. Purpose of the Charter The purpose of this Charter (the "Charter") of the Audit Committee (the "Committee") of the Board of Directors (the "Board") of Virbac Corporation (the "Company") is to establish membership requirements for the Committee and to assist the Committee in complying with its duties under a

Supplement A to the Charter of the Audit Committee of the Board of Directors

EXHIBIT 99.2 SUPPLEMENT A TO THE VIRBAC CORPORATION CHARTER OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS 1. Purpose The Sarbanes-Oxley Act requires the Committee to pre-approve any non-audit related services performed by the Company's independent auditor. The Committee must evaluate these non-audit related services to ensure that such services would not impair the auditor's independence from t

Independent Auditor's Report and Statements

EXHIBIT 99.3 REPORT OF INDEPENDENT AUDITORS To the Board of Directors and Shareholders of King Pharmaceuticals, Inc.: We have audited the accompanying statement of net assets sold and the related statement of revenue and direct expenses (the "Financial Statements") of the Animal Health Product Lines (the Soloxine(R), Pancrezyme(R), Tumil-K(R), Ammonil(R), and Uroeze(R) Product Lines) of King Pharm

1st Amendment to Credit Agreement

EXHIBIT 10.21 AMENDMENT TO CREDIT AGREEMENT THIS AMENDMENT TO CREDIT AGREEMENT, made and entered into as of the 30th day of December, 1999, by and between VIRBAC CORPORATION, a Delaware corporation ("Virbac"), PM RESOURCES, INC., a Missouri corporation ("PM Resources"), ST. JON LABORATORIES, INC., a California corporation ("St. JON"), FRANCODEX LABORATORIES, INC., a Kansas corporation ("Francodex"

Agreement for Temporary Management Services

EXHIBIT 10.26 [EIM LOGO] EXECUTIVE INTERIM MANAGEMENT The Daton Mariok Group, LLC AGREEMENT FOR TEMPORARY MANAGEMENT SERVICES This Agreement for Temporary Executive Services ("Agreement") is entered into as of the 16th day of December 2003, by and between Virbac Corporation (the "Client") and Executive Interim Management ("EIM"); WITNESSETH THAT: WHEREAS, the parties desire to enter into this Agre

Employment Termination, Release and Cooperation Agreement - Thomas Bell

EX 10.28 EMPLOYMENT TERMINATION, RELEASE AND COOPERATION AGREEMENT Virbac Corporation ("the Company") and Thomas Bell ("Employee") agree that the following sets forth their full and complete agreement and understanding regarding the termination of the Employee's employment with the Company: 1. As used in this Agreement the following terms shall have the following meanings. a) Securities Litigation

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2003 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER: 0-2431

Employment Termination, Release and Cooperation Agreement - Joseph Rougraff

EXHIBIT 10.27 EMPLOYMENT TERMINATION, RELEASE AND COOPERATION AGREEMENT Virbac Corporation ("the Company") and Joseph Rougraff ("Employee") agree that the following sets forth their full and complete agreement and understanding regarding the termination of the Employee's employment with the Company: 1. As used in this Agreement the following terms shall have the following meanings. a) Securities L

EX-21.1

. . . EXHIBIT 21.1 SUBSIDIARIES OF VIRBAC CORPORATION NAME STATE OF INCORPORATION PERCENTAGE OF VOTING POWER Delmarva Laboratories, Inc. Virginia 100% PM Resources, Inc. Missouri 100% St. Jon Laboratories, Inc. California 100% Virbac AH, Inc. Delaware 100% Francodex Laboratories, Inc. Kansas 100%

Employment and Consulting Agreement - David Eller

EXHIBIT 10.29 VIRBAC CORPORATION FORM 10-K SEPTEMBER 30, 2003 Employment and Consulting Agreement by and between Virbac Corporation and David Eller, dated as of June 18, 2004. EMPLOYMENT AND CONSULTING AGREEMENT This Employment and Consulting Agreement, effective June 18, 2004, is made by and between Virbac Corporation, a Delaware corporation (hereinafter "Virbac" or the "Corporation") and David E

Code of Business Conduct and Ethics

EXHIBIT 14.1 VIRBAC CORPORATION CODE OF BUSINESS CONDUCT & ETHICS 1. PURPOSE Virbac Corporation ("Virbac") is committed to conducting its business with the highest level of integrity. Virbac is adopting this Code of Business Conduct & Ethics (the "Code of Ethics") for its directors, officers and employees. An uncompromising commitment to this Code of Ethics is essential to the maintenance of Virba

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

SEC 1344 (2-2002) Previous versions obsolete Persons who potentially are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): January 13, 2005 VIRBAC CORPORATION (Exact name

e8vk Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): January 13, 2005 VIRBAC CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-24312 43-1648680 (State of Incorporation) (Commission File No.) (IRS Emp

VIRBAC CORPORATION RECEIVES WELLS NOTICE FROM SEC

exv99w1 Exhibit 99.1 Ms. Jean M. Nelson Executive Vice-President and Chief Financial Officer 817-831-5030 FOR IMMEDIATE RELEASE VIRBAC CORPORATION RECEIVES WELLS NOTICE FROM SEC FORT WORTH, TX, January 13, 2005 — Virbac Corporation (PK: VBAC), a leading marketer of veterinary products, has been notified by the staff of the Securities and Exchange Commission (“SEC”) that the staff is considering re

VIRBAC CORPORATION PROVIDES UPDATE REGARDING RESTATEMENT AND RELATED MATTERS

exv99w1 Exhibit 99.1 Ms. Jean M. Nelson, Chief Financial Officer 817-831-5030 FOR IMMEDIATE RELEASE VIRBAC CORPORATION PROVIDES UPDATE REGARDING RESTATEMENT AND RELATED MATTERS FORT WORTH, TX, November 8, 2004 — Virbac Corporation (PK: VBAC) has advised its shareholders and others interested in the Company’s progress that prior statements regarding the Company’s estimated or projected performance

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 November 8, 2004 Date of Report (Date of earliest event reported) VIRBAC CORPORATIO

e8vk Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

VIRBAC CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K þ ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (No Fee Required) For the fiscal year ended December 31, 2003 o TRAN

e11vk VIRBAC CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

VIRBAC CORPORATION APPOINTS NEW CHIEF EXECUTIVE OFFICER

exv99w1 VIRBAC CORPORATION Ms. Jean M. Nelson, Chief Financial Officer 817-831-5030 FOR IMMEDIATE RELEASE VIRBAC CORPORATION APPOINTS NEW CHIEF EXECUTIVE OFFICER FORT WORTH, TX, October 1, 2004 – Virbac Corporation (OTC BB: VBAC.PK) announced today that it has appointed Dr. Erik R. Martinez as the Company’s President and Chief Executive Officer. Dr. Martinez began his career with Virbac, an affili

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8–K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 October 1, 2004 Date of Report (Date of earliest event reported) VIRBAC CORPORATION

e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8–K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 October 1, 2004 Date of Report (Date of earliest event reported) VIRBAC CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-24312 (Commission File Number)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported) June 3, 2004 VIRBAC CORPORATION (for

e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported) June 3, 2004 VIRBAC CORPORATION (formerly Agri-Nutrition Group Limited) (Exact Name of Registrant as Specified in Its Charter) Delaware 0-24312 43-1648680 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.

VIRBAC CORPORATION HIRES NEW CFO

exv99w1 VIRBAC CORPORATION EXHIBIT 99.1 David G. Eller, President & CEO 817-831-5030 FOR IMMEDIATE RELEASE VIRBAC CORPORATION HIRES NEW CFO FORT WORTH, TX, June 3, 2004 – Virbac Corporation (OTC BB: VBAC.PK) has announced that Jean Nelson will be joining the Company’s senior management team as its Chief Financial Officer. Ms. Nelson is a Certified Public Accountant and began her career on the audi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported) April 30, 2004 VIRBAC CORPORATION (f

e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported) April 30, 2004 VIRBAC CORPORATION (formerly Agri-Nutrition Group Limited) (Exact Name of Registrant as Specified in Its Charter) Delaware 0-24312 43-1648680 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.

VIRBAC CORPORATION’S FRENCH PARENT ISSUES STATEMENT

exv99w1 EXHIBIT 99.1 VIRBAC CORPORATION David G. Eller, President & CEO 817-831-5030 Bill Barry 817-296-0201 FOR IMMEDIATE RELEASE VIRBAC CORPORATION’S FRENCH PARENT ISSUES STATEMENT FORT WORTH, TX, April 30, 2004 — Virbac Corporation (OTC BB: VBAC.PK), announced today that its French affiliate has made the following statement regarding the inclusion of estimated financial information in its estim

VIRBAC CORPORATION ANNOUNCES SEC INVESTIGATION

exv99w1 EXHIBIT 99.1 VIRBAC CORPORATION David G. Eller, CEO 817-831-5030 FOR IMMEDIATE RELEASE VIRBAC CORPORATION ANNOUNCES SEC INVESTIGATION FORT WORTH, TX, February 19, 2004 – Virbac Corporation (VBAC.PK) today announced that it was contacted by the United States Securities and Exchange Commission on February 13, 2004 and advised that the SEC has initiated a formal investigation of Virbac. The S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported) February 19, 2004 VIRBAC CORPORATION

e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported) February 19, 2004 VIRBAC CORPORATION (formerly Agri-Nutrition Group Limited) (Exact Name of Registrant as Specified in Its Charter) Delaware 0-24312 43-1648680 (State or Other (Commission (I.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported) February 6, 2004 VIRBAC CORPORATION (formerly Agri-Nutrition Group Limited) (Exact Name of Registrant as Specified in Its Charter) Delaware 0-24312 43-1648680 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.

VIRBAC CORPORATION

exv99w1 EXHIBIT 99.1 VIRBAC CORPORATION Contact: Michael Porter Porter, LeVay & Rose 212.564.4700 FOR IMMEDIATE RELEASE VIRBAC CORPORATION ANNOUNCES EXECUTIVE RESIGNATIONS Fort Worth, TX, February 6, 2004 – In connection with the ongoing review of the company’s financial reporting, Virbac Corporation (VBAC.PK), today announced that Thomas L. Bell, formerly a director and the Chief Executive Office

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Ac

OMB APPROVAL OMB Number: 3235-0287 Expires: September 30, 1998 Estimated average burden hours per response.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Ac

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2002 Virbac Corporation (former

Virbac Corporation Form 8-K Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.

EX-99.1 Presentation

EXHIBIT 99.1